Mitral chordae myxoma—chordae replacement with a premeasured gore-tex loop using a minimally invasive video-assisted approach by Masatoshi Hata et al.
Hata et al. Journal of Cardiothoracic Surgery 2013, 8:227
http://www.cardiothoracicsurgery.org/content/8/1/227CASE REPORT Open AccessMitral chordae myxoma—chordae replacement
with a premeasured gore-tex loop using a
minimally invasive video-assisted approach
Masatoshi Hata*, Jan F Gummert, Jochen Börgermann and Kavous Hakim-MeibodiAbstract
Cardiac myxomas are one of the most common types of primary cardiac tumors and are associated with
embolization, angina, and sudden death. Most cardiac myxomas arise from the fossa ovalis, while those that arise
from the mitral valve are exceedingly rare and those that arise from the chordae are even rarer. We report the
case of a 28-year-old Caucasian woman who suffered from a brain infarction. A duplex ultrasound showed no
cerebrovascular stenosis or occlusion, but an echocardiogram revealed a left ventricle pedunculated mobile
mass (5 mm in diameter) that was attached to the mitral valve chordae tendineae. We elected cardiac surgery
to resect the cardiac tumor and to avoid further embolic events. The traditional surgical strategy—mitral valve
replacement through full sternotomy—has many disadvantages, particularly for young women. Therefore we
desided to use the Premeasured Gore-Tex chordal loop method followed by annuloplasty using a minimally invasive
video-assisted approach. Exploration of the mitral valve showed a globular tumor involving the anterior mitral leaflet
chordae tendineae, which was removed along with the involved chordae tendineae. Histopathological examination
of the tissue revealed a benign polypoid myxoma. The patient had an uneventful recovery and has remained
symptom-free.
Echocardiography one week after surgery showed satisfactory valve function. We believe our surgical treatment was
the most appropriate option for this case and it resulted in an excellent medical outcome and improved the quality
of life, including only a small lateral scar without the need for teratogenic anticoagulants.
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Cardiac myxomas are one of the most common types of
primary cardiac tumors and are thought to develop from
primitive endothelial or subendocardial cells or from
multipotential mesenchymal cells and can occur within
any of the cardiac chambers. However they have a predi-
lection to occur in the atria, particularly the left atria.
Myxomas that arise from the mitral valve are exceed-
ingly rare and those from the chordae are still rarer
[1-3]. Yuan reported that of the 64 mitral myxomas de-
scribed in publications (42 articles) from 2006 to June
2011, only one arose from the chordate [3].* Correspondence: mhata@hdz-nrw.de
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A 28-year old Caucasian woman without significant risk
factors for atherosclerosis presented with headache, right
hemiplegia, and right visual impairment. Magnetic res-
onance imaging revealed a fresh left posterior brain
infarction. A duplex ultrasound showed no cerebrovascu-
lar stenosis or occlusion, but an echocardiogram revealed
a left ventricle pedunculated mobile mass (5 mm in
diameter) that was attached to the mitral valve chordae
tendineae (Figure 1). Left and right ventricular functions
were normal, and mitral valve regurgitation was mild.
Because the patient did not exhibit findings indicative
of having an embolic source, we elected cardiac surgery
to resect the cardiac tumor and to avoid further em-
bolic events.d. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Transthoracic echocardiography showing a tumor
(5 × 6 mm) on the chordae of anterior leaflet of mitral valve.
Figure 2 Myxoma on the chordae of anterior leaflet of mitral
valve (A2, 3).
Figure 3 A premeasured Gore-Tex loop (18 mm) was fixed to
the body of the papillary muscle and the four free loops from
this suture are secured to the anterior leaflet (A2, 3) at the line
of coaptation.
Hata et al. Journal of Cardiothoracic Surgery 2013, 8:227 Page 2 of 4
http://www.cardiothoracicsurgery.org/content/8/1/227Surgical technique
A CPB was instituted via the femoral arterial and venous
cannulation through a 3 cm transverse incision in the
right groin. The tip of the venous cannula was posi-
tioned under transesophageal echocardiographic guid-
ance in the superior vena cava. The temperature of the
patient was cooled to 34°C, and vacuum-assisted CPB
was used throughout the procedure. A right lateral
mini-thoracotomy (length, 5 cm) was performed via the
4th intercostal space, and the incision was placed in
the submammary crease. A video camera was inserted
through a 10 mm port in the right 3rd intercostal space
and a transthoracic aortic cross-clamp was inserted
through the 3rd intercostal space. Antegrade cold blood
cardioplegia was administered directly into the aortic
root and repeated every 20 min. throughout the proced-
ure, the surgical field was flooded with carbon dioxide
via the camera-port. The left atrium was opened poster-
ior to the interatrial groove. Exploration of the mitral
valve showed a globular tumor involving the anterior
mitral leaflet chordae tendineae (Figure 2), which was
removed along with the involved chordae tendineae.
Neochordae were implanted using the loop technique.
The required length of the loop was determined by
measuring the distance between the correct plane of ap-
position on an adjacent nonprolapsing segment and the
respective papillary muscle. A premeasured Gore-Tex
loop (22 mm) was fixed to the body of the papillary
muscle, and the four free loops from this suture were se-
cured to the resected portion (A2,3) of the anterior leaf-
let at the coaptation line. The sealing-test with a saline
solution showed incompetence, because of the short mitral
leaflet and too small coaptation. Therefore, we removed
the 22 mm Gore-Tex loop and implanted an 18 mm Gore-
Tex loop with the same maneuver (Figure 3). Additionally,an annuloplasty with a 28-mm CE-Physio-ring (Edwards
Lifesciences, Irvine, CA) was performed.
Results
Histopathological examination of the tissue revealed a
benign polypoid myxoma. The patient had an uneventful
postoperative course and was discharged on the 7th
postoperative day. An echocardiography one week after
surgery showed satisfactory valve function with slight
central regurgitation.
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Cardiac myxomas are primary cardiac tumors that are
thought to develop from primitive endothelial or suben-
docardial cells or from multipotential mesenchymal cells
and can occur within any of the cardiac chambers. How-
ever they have a predilection to occur in the atria, par-
ticularly the left atria. Myxomas that arise from the
mitral valve are exceedingly rare and those from the
chordae are still rarer [1-3]. Yuan reported that of the 64
mitral myxomas described in publications (42 articles)
from 2006 to June 2011, only one arose from the chordate
[3]. Thus, our case represents an extremely rare example
of such a myxoma.
Cardiac myxomas are associated with embolization,
angina, and sudden death [1-3]. When they arise from
the left ventricular chamber, the risk of sudden death
due to embolization may increase because of the high
mobility and pressure in the ventricle.
Therefore, a prompt surgical management of these
tumors is necessary if no major contraindications are
present. In addition, myxoma recurrence has been re-
ported to occur at different rates in surgically-treated pa-
tients and at the site of initial localization [2]. Currently,
radical resection is the gold standard for preventing
myxoma recurrence. However, sometimes radical resec-
tion may handicap the patient, particularly when a heart
valve is replaced.
In the young woman of our study, who could become
pregnant in the future, the myxoma involved the an-
terior mitral leaflet chordae tendineae, necessitating
complete resection of the involved chordae. The trad-
itional surgical strategy—mitral valve replacement through
full sternotomy—has many disadvantages, particularly for
young women.
Anticoagulants are necessary after valve replacement
with a mechanical valve, which is contraindicated in
pregnancy. Thus, replacement with a biological valve is
the gold standard for young women who may become
pregnant in future. However, the durability of a bio-
logical valve is worth than a mechanical valve.
We have used the “Premeasured Gore-Tex chordal
loop method” using a minimally invasive video-assisted
approach, reported by von Oppell and Mohr [4] and is
now a standard procedure used for mitral valve prolapse.
Several additional repair techniques for prolapse of an-
terior mitral leaflet such as triangular leaflet resection,
edge to edge repair and others have been developed.
However, these techniques may require smaller ring size
than chordae replacement for annuloplasty in cases with
short mitral leaflets. Since the introduction of ePTFE as
a chordal substitute, low frequency of MR recurrence
after chordal replacement has been reported. Moreover,
as Pfannmüller et al. have described that the premea-
sured loop technique is a highly reproducible methodfor chordal replacement and can be successfully per-
formed using a minimally invasive approach [5]. Accord-
ingly we use the premeasured Gore-Tex loop technique
in almost all cases with mitral valve prolapse. In this
case, an annuloplasty was performed because of the
short mitral leaflet and small coaptation, but we con-
sider that the annuloplasty was not necessary if the mitral
valve showed an enough coaptation after chordae re-
placement. An echocardiography after surgery showed
slight central regurgitation but it was very small and not
hemodynamic relevant. New devices such as “adjustable
length mitral valve chordae” are introduced and clinical
trials are running at present [6,7]. Such technologies may
improve the technical feasibility of chordal repair in the
future.
We believe our surgical treatment was the most ap-
propriate option for this case and it resulted in an excel-
lent medical outcome and improved the quality of life,
including only a small lateral scar without the need for
teratogenic anticoagulants.
Conclusion
We report an extremely rare case of a myxoma that arose
from the mitral valve chordae tendineae. We successfully
performed a minimally invasive surgery, tumor resection
and replacement of only the involved parts of the chordae
tendineae through a ateral mini-thoracotomy.
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